Impaired bile secretion promotes hepatobiliary injury in Sickle Cell Disease.
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA541984 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR9030880_1.fastq.gz | Fastqsanger.gz | |||
| SRR9030880_2.fastq.gz | Fastqsanger.gz | |||
| SRR9030881_1.fastq.gz | Fastqsanger.gz | |||
| SRR9030881_2.fastq.gz | Fastqsanger.gz | |||
| SRR9030882_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 12 |
Similar Datasets
Project description:Sickle cell disease leads to impaired bile secretion and loss of bile transport
2021-01-29 | GSE130935 | GEO
Project description:Background and aimsHepatic crisis is an emergent complication affecting patients with sickle cell disease (SCD); however, the molecular mechanism of sickle cell hepatobiliary injury remains poorly understood. Using the knock-in humanized mouse model of SCD and SCD patient blood, we sought to mechanistically characterize SCD-associated hepato-pathophysiology applying our recently developed quantitative liver intravital imaging, RNA sequence analysis, and biochemical approaches.Approach and resultsSCD mice manifested sinusoidal ischemia, progressive hepatomegaly, liver injury, hyperbilirubinemia, and increased ductular reaction under basal conditions. Nuclear factor kappa B (NF-κB) activation in the liver of SCD mice inhibited farnesoid X receptor (FXR) signaling and its downstream targets, leading to loss of canalicular bile transport and altered bile acid pool. Intravital imaging revealed impaired bile secretion into the bile canaliculi, which was secondary to loss of canalicular bile transport and bile acid metabolism, leading to intrahepatic bile accumulation in SCD mouse liver. Blocking NF-κB activation rescued FXR signaling and partially ameliorated liver injury and sinusoidal ischemia in SCD mice.ConclusionsThese findings identify that NF-κB/FXR-dependent impaired bile secretion promotes intrahepatic bile accumulation, which contributes to hepatobiliary injury of SCD. Improved understanding of these processes could potentially benefit the development of therapies to treat sickle cell hepatic crisis.
| S-EPMC7923682 | biostudies-literature
Project description:Background: Myosin 5b (Myo5b) is a motor protein critical for trafficking proteins to the apical surface of intestinal epithelial cells. Inactivating mutations in MYO5B cause Microvillus Inclusion Disease (MVID), a congenital diarrhea disorder that often leads to liver cholestasis. While Myo5b’s role in the intestine is well characterized, its function in the liver remains unclear. Methods & Results: To define the hepatic consequences of Myo5b loss, we analyzed germline Myo5b knockout (KO) mice. Bulk RNA-seq of KO livers revealed significant transcriptomic alterations, notably downregulation of genes linked to cell proliferation. Immunostaining confirmed reduced Ki67, phospho-histone H3, and cyclin D1 expression, along with impaired growth of liver organoids in Myo5b deficient mice. Histology and lipid staining showed steatosis and enlarged lipid droplets, with gene signatures favoring lipogenesis and ketogenesis in mice lacking Myo5b. Myo5b KO livers also displayed disrupted zonated gene expression and loss of zone 1 and zone 3 markers. Bile acid profiling revealed reduced hepatic bile acid levels, decreased expression of classical pathway genes (Cyp7a1, Cyp7b1), and compensatory upregulation of Cyp27a1. In the ileum, we observed mislocalization of the apical bile acid transporter ASBT and decreased levels of basolateral OSTβ, leading to impaired enterohepatic recycling and increased luminal bile acids. Conclusions: These findings reveal a previously unrecognized role for Myo5b in liver proliferation, metabolic zonation, and bile acid homeostasis, highlighting its importance in maintaining hepatobiliary function.
2026-01-11 | GSE315772 | GEO
Project description:The liver parenchyma is composed of hepatocytes and bile duct epithelial cells (BECs). Controversy exists regarding the cellular origin of human liver parenchymal tissue generation during embryonic development, homeostasis or repair. Here we report the existence of a hepatobiliary hybrid progenitor (HHyP) population in human fetal liver using single-cell RNA sequencing. HHyPs are anatomically restricted to the ductal plate of fetal liver and maintain a unique transcriptional profile distinct from fetal hepatocytes, mature hepatocytes and mature BECs. In addition, molecular heterogenicity within the EpCAM+ population of freshly isolated fetal and adult human liver reveals diverse gene expression signatures of hepatic and biliary lineage potential. Finally, we FACS isolated fetal HHyPs and confirmed their hybrid progenitor phenotype in vivo. Our study suggests that hepatobiliary progenitor cells previously identified in mice also exist in humans, and can be distinguished from other parenchymal populations, including mature BECs, by distinct gene expression profiles.
2019-05-21 | GSE130473 | GEO
Project description:This project is to identify plasma glycoprotein markers for hepatobiliary cancers
2019-11-12 | PXD013629 | Pride
Project description:Hepatocyte nuclear factor 4β (Hnf4β), a nuclear receptor superfamily member, acts as a key regulator of functional gene expression and various cellular processes. The function of Hnf4β in metabolic diseases or infectious diseases had not yet defined in teleost. Here, we show that zebrafish Hnf4β plays a protective role in the host defense against dexamethasone (DEX)-induced hepatobiliary syndrome and hepatobiliary syndrome complicated with GCRV-II infection. Zebrafish Hnf4β deficiency have hepatomegaly, lipid deposition, impairs larvae survival and regulates the expression levels of many genes involved in oxidative phosphorylation and spliceosome during DEX treatment plus GCRV-II infection. In addition, Hnf4β gene disruption in zebrafish leads to induction of oxidative stress with the increased susceptibility to dexamethasone-induced hepatobiliary syndrome complicated with GCRV-II infection. Furthermore, we show that zebrafish Hsp70 promote the translocation of Hnf4β from the nucleus to the cytoplasm and interact with Hnf4β in the cytoplasm and nucleus at DEX + GCRV situation. Mechanistically, zebrafish Hnf4β mediates the beneficial effect for larvae survival and lipid metabolism in the case of DEX treatment plus GCRV-II infection is depending on the Hsp70-mediated autophagy. Collectively, our results identify that the mechanisms of zebrafish Hnf4β through targeting Hsp70 against dexamethasone-induced hepatobiliary syndrome complicated with GCRV-II infection.
2026-01-01 | GSE303991 | GEO
Project description:This project is to identify plasma glycoprotein markers for hepatobiliary cancers
2020-08-31 | MSV000086047 | MassIVE
Project description:Neuroendocrine neoplasms of the gallbladder and liver occur rarely in dogs and humans. A recent reclassification of human neuroendocrine neoplasms by the World Health Organization has refined categorization of these tumors by morphology, replicative indices, and molecular signatures. In humans, these factors correlate with survival outcomes. Improved characterization of these tumors is needed in dogs to identify diagnostic biomarkers and determine therapeutic strategies. To achieve this objective, the proteome of 3 canine hepatobiliary neoplasms was compared to normal canine adrenal and liver tissue from formalin-fixed paraffin-embedded samples. Thirty-two upregulated and 121 downregulated differentially expressed proteins were identified in the hepatobiliary neuroendocrine neoplasm samples. Among the upregulated proteins is galectin-1, a multivalent carbohydrate binding protein known to play a role in lung and pancreatic neuroendocrine neoplasia development and progression in humans. Drugs targeting the galectin family have shown promise as anticancer therapeutics in cervical cancer, prostate cancer, lung and pancreatic neuroendocrine neoplasia in human medicine. Galectin-1 may represent a novel treatment target in hepatobiliary neuroendocrine neoplasia in both humans and dogs.
2023-03-11 | PXD028822 | Pride
Project description:IgG4-related cholangitis (IRC) is the hepatobiliary manifestation of IgG4-related disease, a systemic B-cell-driven fibroinflammatory disorder. Four autoantigens have recently been described in IgG4-RD; annexin A11, galectin-3, laminin 511-E8, and prohibitin 1. We have previously reported a protective role of annexin A11 and laminin 511-E8 in human cholangiocytes against toxic bile acids. Here we explored a potentially protective role of the carbohydrate binding lectin galectin-3 and the scaffold proteins prohibitin 1 and 2.
2024-01-23 | PXD042856 | Pride
Project description:Hepatobiliary syndrome is caused by the impairment of liver fat metabolism in fish, which leads to the weakening or loss of hepatobiliary function. Also, metabolic hepatobiliary syndrome leads to low immune resistance of diseased fish, which is easily induce fish to be infected with other bacterial or viral diseases. By treating wild-type zebrafish larvae with different concentrations of dexamethasone, we found that dexamethasone induced hepatomegaly, hepatic lipid deposition and reduced survival in zebrafish. In addition, dexamethasone treatment combined with GCRV-II infection aggravated lipid deposition in the liver and impaired the survival of zebrafish larvae. Transcriptome data showed that autophagy signaling pathways and blood pressure regulation pathways are significantly enriched. Furthermore, we treated zebrafish larvae with autophagy inhibitor and HSP90 inhibitor, dexamethasone and GCRV-II infection, then found that the survival of zebrafish larvae was improved, liver lipid deposition was attenuated, and ROS production was greatly reduced. In conclusion, this study provides insights into the regulation of immune metabolism in zebrafish hepatobiliary syndrome and GCRV-II infection, and provides potential molecular targets for the prevention and control of metabolic disease-induced infectious diseases in other cyprinids.
2025-08-28 | GSE275683 | GEO